INCOME STATEMENT
Aarti Drugs Ltd.
BSE
Jun 16, 11:32
456.35
-7.65 ( -1.65%)
Volume
7672
Prev. Close
464.00
Open Price
463.50
Bid Price(Qty.)
455.70 (7)
Offer Pr.(Qty.)
456.45 (18)
NSE
Jun 16, 11:19
457.10
-6.65 ( -1.43%)
Volume
68395
Prev. Close
463.75
Open Price
460.05
Bid Price(Qty.)
457.05 (27)
Offer Pr.(Qty.)
457.45 (15)
You can view the
Income Statement
for the last 5 years.
ISIN No
|
INE767A01016
|
Market Cap. ( ₹ in Cr. )
|
4171.95
|
P/BV
|
3.27
|
Book Value ( ₹ )
|
139.96
|
BSE Code
|
524348
|
52 Week High/Low ( ₹ )
|
635/312
|
FV/ML
|
10/1
|
P/E(X)
|
24.81
|
NSE Code
|
AARTIDRUGSEQ
|
Book Closure
|
04/02/2025
|
EPS ( ₹ )
|
18.42
|
Div Yield (%)
|
0.22
|
(₹ in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 2173.65 | 2253.74 | 2488.71 | 2251.17 | 1914.89 |
Other Operating Revenues | 0.00 | 13.17 | 9.26 | 0.00 | 0.00 |
Total Operating Revenues | 2173.65 | 2266.91 | 2497.97 | 2251.17 | 1914.89 |
| | | | | |
Other Income | 13.58 | 4.18 | 2.23 | 4.77 | 6.42 |
Total Revenue | 2187.23 | 2271.09 | 2500.20 | 2255.95 | 1921.31 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 1358.34 | 1466.57 | 1702.44 | 1524.56 | 1127.79 |
Purchase Of Stock-In Trade | 44.34 | 35.86 | 47.01 | 58.31 | 43.17 |
Operating And Direct Expenses | 0.00 | 326.86 | 319.57 | 282.81 | 222.37 |
Changes In Inventories Of FG,WIP And Stock-In Trade | 22.00 | 26.77 | -6.72 | -77.94 | -9.08 |
Employee Benefit Expenses | 85.25 | 80.98 | 74.99 | 69.32 | 69.29 |
Finance Costs | 29.68 | 30.16 | 32.53 | 20.07 | 22.61 |
Depreciation And Amortisation Expenses | 47.79 | 47.67 | 47.29 | 47.39 | 47.60 |
Other Expenses | 401.08 | 63.74 | 78.27 | 75.94 | 60.09 |
Total Expenses | 1988.48 | 2078.61 | 2295.39 | 2000.45 | 1583.83 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 198.75 | 192.48 | 204.81 | 255.50 | 337.49 |
| | | | | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.22 |
Profit/Loss Before Tax | 198.75 | 192.48 | 204.81 | 255.50 | 337.71 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 41.44 | 49.60 | 53.25 | 65.50 | 84.50 |
Deferred Tax | 0.00 | 1.00 | -1.25 | -5.00 | -4.50 |
Total Tax Expenses | 41.44 | 50.60 | 52.00 | 60.50 | 80.00 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 157.31 | 141.88 | 152.81 | 195.00 | 257.71 |
| | | | | |
Profit/Loss From Continuing Operations | 157.31 | 141.88 | 152.81 | 195.00 | 257.71 |
| | | | | |
Profit/Loss For The Period | 157.31 | 141.88 | 152.81 | 195.00 | 257.71 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 17.18 | 15.35 | 16.50 | 21.04 | 27.65 |
Diluted EPS (Rs.) | 17.18 | 15.35 | 16.50 | 21.04 | 27.65 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 0.00 | 9.19 | 9.26 | 9.26 | 23.30 |
Equity Dividend Rate (%) | 10.00 | 10.00 | 10.00 | 10.00 | 25.00 |